Healthcare Sales & Marketing Network News: cancer diagnostics

Searching News Database: cancer diagnostics

HSMN NewsFeed - 5 Sep 2025
Roche Receives CE IVDR Approval for HER2 (4B5) Companion Diagnostic Test to Identify HER2-ultralow Breast Cancer and Biliary Tract Cancer Patients
Diagnostics Oncology Regulatory

HSMN NewsFeed - 21 Aug 2024
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 2 May 2024
PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision Diagnostics
Diagnostics Oncology Personnel

HSMN NewsFeed - 8 Feb 2024
PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
Diagnostics Oncology Personnel

HSMN NewsFeed - 28 Mar 2023
DCISionRT(R) by PreludeDx(TM) Receives Advanced Diagnostic Laboratory Test (ADLT) Status Approval from the Centers for Medicare & Medicaid Services
Diagnostics Oncology

HSMN NewsFeed - 9 Nov 2022
Ibex Medical Analytics Secures $10M Funding from Kreos Capital
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 25 Mar 2022
Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions
Diagnostics

HSMN NewsFeed - 1 Feb 2022
Biofidelity Raises $23M in Series A+ Financing led by Octopus Ventures to Launch ASPYRE Technology
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 1 Feb 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 15 Dec 2021
Roche Launches the First Infectious Disease Tests and Cobas Omni Utility Channel for Use on the Cobas 5800 System in Countries Accepting the CE Mark
Diagnostics Product Launch

HSMN NewsFeed - 9 Mar 2021
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib)
Diagnostics Oncology FDA

HSMN NewsFeed - 29 Oct 2020
Roche receives FDA approval for the cobas EGFR Mutation Test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with non-small cell lung cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 13 Aug 2020
Micronoma Launches with $3 Million Seed Funding
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 15 Jun 2020
Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat(R) Research
Diagnostics Oncology Distribution

HSMN NewsFeed - 17 Mar 2020
Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization
Diagnostics Product Launch

HSMN NewsFeed - 6 Mar 2020
PreludeDx Announces New Response Type Biosignature Data at the 37th Annual Miami Breast Cancer Conference
Diagnostics Oncology

HSMN NewsFeed - 9 Jan 2020
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
Diagnostics Venture Capital

HSMN NewsFeed - 6 Dec 2019
Biovica Strengthens Management Team
Diagnostics Oncology Personnel

HSMN NewsFeed - 25 Sep 2019
Body Vision Closing $20 Million in Series C Funding
Devices Diagnostics Venture Capital

HSMN NewsFeed - 1 Oct 2018
Body Vision Medical Announces the Release of LungVision(TM)
Devices Diagnostics Product Launch

HSMN NewsFeed - 18 Sep 2018
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 23 Aug 2018
Roche receives FDA approval for cobas EGFR Mutation Test v2 as companion diagnostic with IRESSA (gefitinib) in first-line treatment of patients with non-small cell lung cancer (NSCLC)
Diagnostics Oncology FDA

HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Devices Monitoring Product Launch

HSMN NewsFeed - 14 May 2018
FDA approves additional claim for Roche cobas Zika test
Diagnostics FDA

HSMN NewsFeed - 1 May 2018
Agendia's MammaPrint(R) Receives Positive Coverage Decisions from Three Major Private Healthcare Insurers
Diagnostics Personalized Medicine Oncology Reimbursement

HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Diagnostics FDA

HSMN NewsFeed - 11 Apr 2018
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 21 Mar 2018
Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 8 Mar 2018
Roche launches the new cobas m 511 analyzer, signaling a new era in hematology testing
Diagnostics FDA Product Launch

HSMN NewsFeed - 8 Jan 2018
Clearbridge BioMedics' ClearCell(R) FX1 system achieves U.S. FDA listing
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 19 Dec 2017
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 13 Dec 2017
Leica Biosystems and KUB Technologies, Inc. Announce New Distribution Agreement
Devices Radiology Oncology Distribution

HSMN NewsFeed - 12 Sep 2017
Cernostics Announces Leadership Team Expansion
Diagnostics Oncology Personnel

HSMN NewsFeed - 5 Sep 2017
Morphotek(R), Inc. Announces an Agreement with Fujirebio Diagnostics, Inc. to Commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab(R)
Biopharmaceuticals Diagnostics Oncology Licensing

HSMN NewsFeed - 26 Jul 2017
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
Diagnostics Product Launch

HSMN NewsFeed - 1 Jun 2017
Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients
Diagnostics Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 May 2017
Biotheranostics Appoints Don Hardison as New CEO
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 17 May 2017
Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer
Diagnostics Personnel

HSMN NewsFeed - 1 May 2017
FDA Clears Roche High-Volume Immunoassay Lab Testing Solution to Support Critical Medical Treatment Decisions
Diagnostics FDA

HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Diagnostics Oncology Product Launch

HSMN NewsFeed - 16 Nov 2016
DILON Diagnostics And GE Healthcare Announce Exclusive North America Distribution Agreement For The Discovery NM750b Molecular Breast Imaging System
Devices Radiology Distribution

HSMN NewsFeed - 19 Oct 2016
GeneFirst Announces CE Marking and Release of Papilloplex(R) HR-HPV, a PCR Based Molecular Diagnostic Test for Genotyping 14 High Risk Human Papillomaviruses from Cervical and Urine Samples
Diagnostics Regulatory Product Launch

HSMN NewsFeed - 26 Sep 2016
Roche Receives 510(K) Clearance from FDA for Treponema Pallidum Assay to Aid Clinicians in the Diagnosis of Syphilis Infection
Diagnostics FDA

HSMN NewsFeed - 9 Sep 2016
Prospective, independent study demonstrates the utility of Guardant360 for guiding therapy selection in advanced Non-Small-Cell Lung Cancer
Diagnostics Oncology

HSMN NewsFeed - 29 Aug 2016
Roche receives FDA Emergency Use Authorization for Zika PCR Test
Biopharmaceuticals FDA

HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Diagnostics FDA

HSMN NewsFeed - 19 May 2016
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 23 Mar 2016
Roche Submits Filing to FDA For cobas(R) Procalcitonin (Pct) Assay to Help Clinicians Assess Response of Septic Patients to Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
Diagnostics FDA

HSMN NewsFeed - 8 Jan 2016
Dr. Rolf Muller Appointed as New CEO of BioFluidica, Inc.
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Jan 2016
Guardant Health Secures Series D Financing to Expand the Reach of its Digital Sequencing(TM) Platform in Oncology
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 7 Jan 2016
BioLight Reports Positive Second Clinical Study Results for its TeaRx(TM) Multi-Assay Test for Dry Eye Syndrome
Diagnostics Ophthalmology

HSMN NewsFeed - 21 Dec 2015
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
Diagnostics HIV/AIDS FDA

HSMN NewsFeed - 1 Dec 2015
Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor
Biopharmaceuticals Licensing

HSMN NewsFeed - 15 Oct 2015
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 2 Sep 2015
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 15 Jul 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors
Diagnostics Oncology Personnel

HSMN NewsFeed - 16 Jun 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation
Diagnostics Oncology Personnel

HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Diagnostics FDA

HSMN NewsFeed - 14 May 2015
OncoCyte Corporation Completes Equity Financing Round
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 11 May 2015
Roche Receives FDA Approval for cobas(R) KRAS Mutation Test
Diagnostics Oncology FDA

HSMN NewsFeed - 31 Mar 2015
EDP Biotech Signs Distribution Partnership Agreements for ColoMarker(R) Abroad
Diagnostics Oncology Distribution

HSMN NewsFeed - 3 Feb 2015
Guardant Health Secures Additional $50 Million Based On Strong Demand For Its Biopsy-Free Cancer Blood Test, Guardant360(R)
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 2 Feb 2015
BioLight Reports Successful Clinical Study Results for Monitoring Bladder Cancer Recurrence with the CellDetect(R) Non-Invasive Test
Devices Diagnostics Oncology

HSMN NewsFeed - 26 Jan 2015
Roche receives FDA clearance for next generation cobas MRSA/SA Test
Diagnostics FDA

HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Diagnostics

HSMN NewsFeed - 6 Oct 2014
bioTheranostics Appoints Nicolas Barthelemy as President and CEO
Diagnostics Oncology Personnel

HSMN NewsFeed - 30 Jul 2014
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 30 May 2014
Guardant Health Announces US Commercial Launch of Guardant360(TM): A Breakthrough Blood Test for Real-Time Cancer Patient Treatment Management
Diagnostics Oncology Product Launch

HSMN NewsFeed - 19 May 2014
Biocept Announces National Sales Force
Diagnostics Oncology

HSMN NewsFeed - 28 Apr 2014
Vermillion Launches ASPiRA LABS
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 13 Mar 2014
CombiMatrix Announces Partnership With American Pathology Partners to Provide Products of Conception Testing
Diagnostics

HSMN NewsFeed - 10 Mar 2014
CombiMatrix Hires R. Weslie Tyson, M.D., as Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 26 Feb 2014
Quest Diagnostics Expands Hereditary Cancer Screening Offering with Lynch Syndrome Blood and Biopsy Testing for Colorectal Cancer
Diagnostics Oncology Product Launch

HSMN NewsFeed - 29 Jan 2014
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
Diagnostics Oncology

HSMN NewsFeed - 7 Jan 2014
Guided Therapeutics Names Gene Cartwright as Chief Executive Officer
Devices Diagnostics Oncology Personnel

HSMN NewsFeed - 19 Dec 2013
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
Diagnostics Oncology Personnel

HSMN NewsFeed - 19 Sep 2013
Prometheus Laboratories Appoints Chief Executive Officer
Biopharmaceuticals Personalized Medicine Personnel

HSMN NewsFeed - 12 Mar 2013
Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
Diagnostics Oncology

HSMN NewsFeed - 11 Mar 2013
Precision Therapeutics Announces Topline Prospective Clinical Data Demonstrating Significant Improvement in Overall Survival and Progression Free Survival in Recurrent Ovarian Cancer using Personalized Chemotherapy Diagnostic ChemoFx(R)
Diagnostics Oncology Personalized Medicine

HSMN NewsFeed - 18 Feb 2013
Roche and Chiasma Announce Collaboration to Develop and Commercialize Chiasma's Octreolin(R) for Acromegaly and Neuroendocrine Tumors
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 27 Nov 2012
Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 13 Nov 2012
Epic Sciences Announces Series B Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 28 Oct 2012
IBA and Philips Announce First Installation of Patient-Centered Proton Treatment Room
Devices Oncology

HSMN NewsFeed - 24 Oct 2012
Abbott's ALK Test is Now Available in Europe as a Companion Diagnostic Test to Aid in Identifying Patients for Targeted Lung Cancer Therapy
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 23 Oct 2012
IBA to Showcase Its Full Spectrum of Proton Therapy Solutions and Services at the American Society for Radiation Oncology (ASTRO) Conference
Devices Oncology

HSMN NewsFeed - 1 Oct 2012
Roche Diagnostics ACCU-CHEK Combo Insulin Pump System Now Available in United States
Devices Monitoring Drug Delivery Endocrinology

HSMN NewsFeed - 27 Jul 2012
Roche and AREVA Med Join Forces in the Fight Against Cancer and Create a Novel Radio-Immunotherapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Jul 2012
Agendia Welcomes Dr. Mark Gittleman to Expanding Medical Advisory Board
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 9 Jul 2012
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 26 Jun 2012
Allegro Diagnostics Appoints Clinical and Scientific Advisory Board Comprised of Experts in Pulmonology, Lung Cancer and Molecular Diagnostics
Diagnostics Oncology Personnel

HSMN NewsFeed - 1 Jun 2012
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 17 May 2012
Agilent to Acquire Dako for $2.2 Billion
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 16 May 2012
Roche and HYCOR Sign Global Distribution Agreement
Diagnostics Distribution

HSMN NewsFeed - 7 May 2012
Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
Diagnostics FDA

HSMN NewsFeed - 28 Mar 2012
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 22 Mar 2012
First-Ever Prospective Diagnostic Study in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 6 Mar 2012
Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 20 Feb 2012
FDA Clears ASI’s GenASIs Advanced Imaging for HER-2/neu Analysis
Diagnostics Oncology FDA

HSMN NewsFeed - 2 Feb 2012
Ronnie Andrews Joins Life Technologies as President, Medical Sciences
Diagnostics Personnel

HSMN NewsFeed - 27 Jan 2012
Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 5 Dec 2011
Roche Acquires Verum Diagnostica GmbH as Part of Plan to Develop Comprehensive Coagulation Testing Portfolio for Diagnostic Laboratories
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 24 Oct 2011
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
Diagnostics FDA

HSMN NewsFeed - 6 Sep 2011
FDA Clears Next-Generation Biomarker Test to Determine Likelihood of Ovarian Cancer in Women Who Present with Adnexal Mass
Diagnostics Oncology FDA

HSMN NewsFeed - 27 Aug 2011
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Diagnostics Personalized Medicine Oncology FDA

HSMN NewsFeed - 22 Aug 2011
FDA Clears Abbott's Genetic FISH Panel for Leukemia Patient Prognosis
Diagnostics Oncology FDA

HSMN NewsFeed - 1 Aug 2011
Roche Appoints Mara G. Aspinall President of Ventana Medical Systems, Inc.
Diagnostics Personnel

HSMN NewsFeed - 20 Jul 2011
Neoprobe Establishes European Business Unit
Devices Diagnostics Oncology

HSMN NewsFeed - 19 Jul 2011
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 31 May 2011
Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 26 May 2011
Genetic Technologies Files New Patent Infringement Suit in USA
Biopharmaceuticals Diagnostics Oncology Litigation

HSMN NewsFeed - 19 May 2011
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 28 Mar 2011
Janet Hammond Joins Roche as Vice President, Translational Medicine - Virology
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Mar 2011
Agendia Hires David Macdonald as Chief Operating Officer, Mark Willig as Executive VP of North American Sales, and Doug Bradley as Vice President of Global Marketing
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 31 Jan 2011
CyberKnife Radiosurgery to be Highlighted by Leading Thoracic Surgeons at 2011 STS Annual Meeting
Devices Oncology

HSMN NewsFeed - 18 Jan 2011
Diagnoplex Closes an Extension of its Series A Financing With a Substantial Investment by Debiopharm Group(TM)
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 15 Nov 2010
NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Nov 2010
GE Healthcare Begins Tender Offer to Acquire Clarient, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 29 Oct 2010
Roche Introduces Immunoassay Module for cobas(R) 8000 Modular Analyzer Series In U.S.
Diagnostics

HSMN NewsFeed - 22 Oct 2010
GE Healthcare to Acquire Cancer Diagnostic Company Clarient Inc.
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 13 Oct 2010
Radient Pharmaceuticals and Provista Life Sciences Announce New Blood Test for Lung Cancer
Diagnostics Oncology

HSMN NewsFeed - 22 Sep 2010
Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
Diagnostics FDA

HSMN NewsFeed - 13 Sep 2010
Roche Receives FDA Clearance for U.S. Launch of cobas 8000 Modular Analyzer Series for High-Volume Laboratory Testing
Devices Diagnostics FDA

HSMN NewsFeed - 26 Jul 2010
Roche Receives FDA Clearance for CoaguChek XS Pro system With Bar Code Reader for PT/INR Testing at the Point of Care
Diagnostics FDA

HSMN NewsFeed - 26 Jul 2010
Karen Lackey Named Vice President and Head of Medicinal Chemistry at Roche
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jul 2010
Radient Pharmaceuticals Enters Into a Letter of Intent to Acquire Provista Diagnostics Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 12 Jul 2010
Clarient Announces Publication of Mammostrat(R) Breast Cancer Study in Breast Cancer Research
Diagnostics Oncology

HSMN NewsFeed - 4 Jun 2010
FDA Approves New Roche Dual-PCR Target HIV-1 Test
Diagnostics FDA HIV/AIDS

HSMN NewsFeed - 28 May 2010
Roche Diagnostics Receives FDA Approval for Qualitative Anti-HCV Immunoassay Test on Three Analyzer Platforms
Diagnostics FDA

HSMN NewsFeed - 19 May 2010
Roche and Biogen Idec Announce Their Decision to Discontinue the ocrelizumab Clinical Development Programme in Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 17 Mar 2010
New Data Indicate Effectiveness of Clarient's Ovotax(TM) Test for Ovarian Cancer
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 3 Mar 2010
Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
Diagnostics Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Feb 2010
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
Diagnostics Oncology

HSMN NewsFeed - 19 Jan 2010
OraSure Technologies and Roche Diagnostics Sign Worldwide Commercialization Agreement for Fully Automated Oral Fluid Drugs of Abuse Assays
Diagnostics

HSMN NewsFeed - 18 Jan 2010
AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
Personalized Medicine Diagnostics Biopharmaceuticals

HSMN NewsFeed - 17 Dec 2009
FDA Broadens Clearance for Agendia's MammaPrint(R)
Diagnostics Oncology FDA

HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital

HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
Diagnostics FDA

HSMN NewsFeed - 5 Nov 2009
Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
Devices Cardiology Monitoring Personnel

HSMN NewsFeed - 3 Nov 2009
Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 22 Sep 2009
Agendia Raises US $23 Million in Series E Financing
Diagnostics Venture Capital

HSMN NewsFeed - 31 Aug 2009
FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jun 2009
Clarient Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer
Diagnostics Oncology

HSMN NewsFeed - 12 May 2009
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
Biopharmaceuticals Diagnostics Monitoring Endocrinology

HSMN NewsFeed - 5 May 2009
Clarient Launches New Breast Cancer Test
Diagnostics Oncology

HSMN NewsFeed - 4 May 2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
Diagnostics Oncology

HSMN NewsFeed - 1 May 2009
Fisher HealthCare Becomes Exclusive Distributor of Flow Cytometry Reagents for Dako Reagent Partnership Division
Diagnostics Distribution

HSMN NewsFeed - 24 Apr 2009
Roche Announces Collaboration to Investigate New Treatment Strategy With Tarceva in Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Apr 2009
Newly Published Study Shows That Re-Treatment With Pegasys(R) (Peginterferon Alfa-2a) Provides Hepatitis C Patients With a Second Chance for a Cure
Biopharmaceuticals

HSMN NewsFeed - 18 Feb 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 12 Feb 2009
Celerus Diagnostics Secures $5 Million Series C Financing
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 11 Feb 2009
Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
Diagnostics Oncology

HSMN NewsFeed - 4 Feb 2009
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
Diagnostics Oncology

HSMN NewsFeed - 27 Jan 2009
Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott s Architect(R) Analyzers
Diagnostics Oncology

HSMN NewsFeed - 8 Jan 2009
Agendia Appoints New Chief Financial Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 17 Dec 2008
HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor
Diagnostics Personnel

HSMN NewsFeed - 16 Dec 2008
Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
Diagnostics Oncology Licensing

HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 10 Dec 2008
Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 16 Oct 2008
Predictive Biosciences Closes $21.75 Million in Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 8 Oct 2008
Pathwork Diagnostics Announces Key Additions to Management Team
Diagnostics Personnel

HSMN NewsFeed - 17 Sep 2008
mtm laboratories Launches CINtec(R) Cytology Kit in Europe with Extended Clinical Claims for Cervical Cancer Diagnosis
Diagnostics Regulatory

HSMN NewsFeed - 4 Sep 2008
Agendia Launches TargetPrint(R) for Breast Cancer Patients
Diagnostics Oncology

HSMN NewsFeed - 26 Aug 2008
DiagnoCure receives approval from the U.S. regulatory authorities and launches its Previstage(TM) GCC Colorectal Cancer Staging Test
Diagnostics Oncology Regulatory

HSMN NewsFeed - 9 Jul 2008
BioMarker Strategies Names Karen Olson CEO
Diagnostics Devices Oncology Personnel

HSMN NewsFeed - 1 Jul 2008
Clarient Launches New Colorectal Cancer Test
Diagnostics Oncology

HSMN NewsFeed - 4 Jun 2008
Loic Maurel Joins Exonhit Therapeutics to Become CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 May 2008
LabCorp First Company to Commercially Launch Gene Methylation Test for Prostate Cancer
Diagnostics Oncology

HSMN NewsFeed - 15 Apr 2008
AltheaDx Appoints Vice President of Business Development, Sales and Marketing
Diagnostics Personnel

HSMN NewsFeed - 7 Apr 2008
Robert Palmisano Appointed President, Chief Executive Officer and Director of ev3 Inc.
Devices Interventional Personnel

HSMN NewsFeed - 20 Mar 2008
Vermillion Announces Positive Results From Clinical Trial of Ovarian Tumor Triage Test; Study Meets Primary Endpoints
Diagnostics Oncology

HSMN NewsFeed - 19 Mar 2008
Predictive Biosciences Appoints Life Sciences Industry Veteran Peter Klemm, Ph.D., as Company's First President and CEO
Diagnostics Personnel

HSMN NewsFeed - 13 Mar 2008
Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
Diagnostics Oncology

HSMN NewsFeed - 3 Mar 2008
Celerus Diagnostics Launches Rapid Diagnostic Tool
Diagnostics

HSMN NewsFeed - 19 Feb 2008
Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer
Diagnostics Oncology Licensing

HSMN NewsFeed - 12 Feb 2008
Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
Diagnostics Personnel

HSMN NewsFeed - 22 Jan 2008
Hologic Announces Sale of Gestiva(TM)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 19 Nov 2007
Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
Diagnostics Acquisitions

HSMN NewsFeed - 13 Nov 2007
Ventana Enters into Confidentiality Agreement with Roche
Diagnostics

HSMN NewsFeed - 12 Nov 2007
Diamics Names Ex-Digene Vice President Rodney L. Wallace as SVP of Technology
Diagnostics Personnel

HSMN NewsFeed - 29 Oct 2007
Ventana Responds to Fourth Extension of Roche's Unsolicited, Inadequate Tender Offer
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2007
Ikonisys Closes $30 Million Series E Financing; Investment Reflects Successful Development of Rare Cell Detection Testing Platform
Diagnostics Venture Capital

HSMN NewsFeed - 10 Oct 2007
Transgenomic Names New Sr. VP of Sales and Marketing
Diagnostics Personnel

HSMN NewsFeed - 4 Oct 2007
Cytyc Ships Cellient(TM) Automated Cell Block Systems
Diagnostics

HSMN NewsFeed - 4 Oct 2007
Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
Diagnostics Personnel

HSMN NewsFeed - 3 Oct 2007
Ventana Submits INFORM(TM) HER2 SISH DNA Probe Assay for FDA Approval
Diagnostics Oncology FDA

HSMN NewsFeed - 25 Sep 2007
CombiMatrix Molecular Diagnostics Launches HemeScan MDS for the Management and Diagnosis of Myelodysplastic Syndromes
Diagnostics Oncology

HSMN NewsFeed - 19 Sep 2007
Ventana Responds to Third Extension of Roche's Unsolicited Tender Offer
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 17 Sep 2007
EraGen Announces Appointment of Blanc as Vice President, Corporate Development
Diagnostics Personnel

HSMN NewsFeed - 5 Sep 2007
Ventana Medical Systems Acquires Spring BioScience
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 28 Aug 2007
Inverness Medical Innovations Agrees to Acquire Matritech, Inc.
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 21 Aug 2007
Ventana Responds to Second Extension of Roche's Unsolicited Tender Offer
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 17 Aug 2007
Ventana Medical Systems Comments on Outcome of CytoLogix Litigation
Diagnostics Litigation

HSMN NewsFeed - 26 Jul 2007
Ventana Responds to Roche's Unsolicited Tender Offer Extension
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 11 Jul 2007
Ventana's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 25 Jun 2007
Roche Makes Offer to Acquire Ventana for $75.00 Per Share in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 25 Jun 2007
CombiMatrix Molecular Diagnostics Launches HemeScan(TM) Ploidy Test for the Management of Acute Lymphoblastic Leukemia
Diagnostics Oncology

HSMN NewsFeed - 7 Jun 2007
In 2009 Exonhit Aims to ask for Market Clearance in Europe for a Blood Diagnostic Test for Alzheimer's Disease
Diagnostics Neurology

HSMN NewsFeed - 31 May 2007
Quest Diagnostics Completes Acquisition of AmeriPath
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 28 May 2007
Perceptronix Brings Early Lung Cancer Detection to UK By Signing Service Agreement With University Hospital of Coventry and Warwickshire NHS Trust
Diagnostics Oncology

HSMN NewsFeed - 7 May 2007
Five-Year Results of Cytyc's MammoSite(R) Radiation Therapy System Presented at ASBS Annual Meeting
Devices Oncology

HSMN NewsFeed - 4 May 2007
Bristol-Myers Squibb Joins Oslo Cancer Cluster
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Apr 2007
Quest Diagnostics to Acquire AmeriPath in a Transaction Valued at $2 Billion
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 28 Mar 2007
Cytyc Announces New Multi-Year Agreement with Quest Diagnostics
Diagnostics

HSMN NewsFeed - 16 Mar 2007
Cytyc Corporation Completes Acquisition of Adiana, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 8 Mar 2007
Clarient Sells Its ACIS(R) Instrument Business to Carl Zeiss for $12.5 Million
Diagnostics Acquisitions

HSMN NewsFeed - 27 Feb 2007
ev3 Inc. Appoints Daniel J. Levangie to its Board of Directors
Devices Personnel

HSMN NewsFeed - 27 Feb 2007
Cytyc to Acquire Adiana, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 12 Feb 2007
Cytyc to Acquire Adeza Biomedical Corporation
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 6 Feb 2007
Agendia Receives U.S. FDA Clearance for MammaPrint Breast Cancer Diagnostic Test
Diagnostics FDA

HSMN NewsFeed - 30 Jan 2007
Cytyc Announces New UK NICE Clinical Guideline Recommends Endometrial Ablation Instead of Hysterectomy For Most Women with Heavy Menstrual Bleeding
Devices

HSMN NewsFeed - 24 Jan 2007
Ikonisys Receives FDA Clearance for Automated Bladder Cancer Test
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 20 Dec 2006
RedPath Integrated Pathology, Inc. Concludes Series A Round With $6.5 Million in Venture Capital
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 20 Dec 2006
BD Completes Acquisition of TriPath Imaging
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 4 Dec 2006
Abbott Introduces CE-Marked DNA Tests in Europe for the Detection of Chromosomal Abnormalities Associated With Leukemia
Diagnostics Oncology

HSMN NewsFeed - 13 Nov 2006
Twelve Studies Evaluating Cytyc's MammoSite(R) Radiation Therapy System Presented at ASTRO Annual Meeting
Devices Oncology

HSMN NewsFeed - 6 Nov 2006
Matritech and Inverness Medical Innovations Sign Agreements for the Manufacturing and OTC Distribution of the NMP22(R) BladderChek(R) Test
Diagnostics Oncology Distribution

HSMN NewsFeed - 27 Oct 2006
James Godsey, Ph.D., to Join Digene as Senior Vice President Research and Development
Diagnostics Personnel

HSMN NewsFeed - 4 Oct 2006
Dako Receives FDA Approval for Use of EGFR pharmDx(TM) With Vectibix(TM)
Diagnostics FDA Oncology

HSMN NewsFeed - 28 Sep 2006
Ikonisys Receives FDA Clearance for Prenatal Testing Application
Diagnostics FDA

HSMN NewsFeed - 20 Sep 2006
Breast Cancer Screening Improved With New Palpation Imaging Technology, Study Finds
Devices Oncology

HSMN NewsFeed - 8 Sep 2006
BD to Acquire TriPath Imaging, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 28 Jun 2006
Panacea Pharmaceuticals Announces Appointment of Stephen N. Keith, MD, MSPH as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 May 2006
Abbott Enters Agreement With Advanced Life Science Institute to Develop Lung Cancer Test
Diagnostics Oncology

Return to NewsFeed

Additional items found! 41

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 41 additional stories matching:
cancer diagnostics
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!